homepee.com

ÇÐȸ ¹× ÈÄ¿ø

ÇÐȸ ¹× ÈÄ¿ø

¡å

  • CUSTOMER
  • 02-3425-1139
  • am 08:00 ~ pm 06:00
¿Â¶óÀι®ÀÇ
  • Home
  • ÇÐȸ ¹× ÈÄ¿ø
  • ICNIM

ICNIMÇÐȸ ¹× ÈÄ¿ø

Á¦¸ñ Á¦7ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ
ÀÛ¼ºÀÚ KCFKOREA
ÀÛ¼ºÀÏÀÚ 2019-04-09


 
 
 
Á¦7ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ  
°³ÃÖ Àå¼Ò : »ñÆ÷·Î½Ã(·ÎÀÌÆ° »ñÆ÷·Î)   
ÁÖÃÖ : AHCC ¿¬±¸È¸  
ÈÄ¿ø : ÁÖ½Äȸ»ç ¾Æ¹Ì³ë¾÷È­ÇР

 

Á¦7ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ°¡ ÀϺ» »ñÆ÷·Î¿¡¼­ °³ÃֵǾú½À´Ï´Ù.
AHCC ¿¬±¸È¸´Â AHCC¿¡ ´ëÇÑ ÀÇ·á°ü°èÀÚµé ÇÑ ÇØ µ¿¾ÈÀÇ ¿¬±¸, ¼º°ú, Á¤º¸ µîÀ» ³ª´©°í
¹ßÇ¥ÇÏ´Â ÀÚ¸®ÀÔ´Ï´Ù.
À̹ø Á¦7Â÷ AHCC ¿¬±¸È¸ ±¹Á¦ÇÐȸ¿¡¼­´Â °¢Á¾ ¾Ï¿¡¼­ÀÇ AHCC¿¡ ¿ªÇÒ¿¡ ´ëÇÑ °­¿¬ÀÌ ÁÖ¸¦ ÀÌ·ð½À´Ï´Ù.
ƯÈ÷, ¾Ï°ú °°Àº º´À» °¡Áö°í Àְųª Ä¡·á ÈÄ È¯ÀÚÀÇ »îÀÇ Áú QOL[ quality of life ]¿¡ °üÇÑ
°­¿¬ÀÌ ¿©·¯ °Ç ¹ßÇ¥µÇ¾ú½À´Ï´Ù.
ȯÀÚÀÇ Áúº´ Ä¡·á»Ó¸¸ ¾Æ´Ï¶ó ´õ ³ª¾Æ°¡ ȯÀÚÀÇ »îÀÇ Áú QOL[ quality of life ]µµ Áß¿äÇÑ ¿äÀÎÀ̶ó´Â °ÍÀ» ¾Ë ¼ö ÀÖ´Â ÀÚ¸®¿´½À´Ï´Ù.
 
 
 
General Lecture

¡°Suppressive effect of AHCC on acute inflammation¡±
Masatoshi Yamazaki, et al. £¨Teikyo University, Japan£©
¡°Protective effects of AHCC on opportunistic infection in experimental murine model¡±
Shigeru Abe, et al. £¨Teikyo University, Japan£©
¡°Suppressive effect of AHCC on thymocyte apoptosis in rat¡±
Shigeru Matsuzaki, et al. £¨Dokkyo University School of Medicine, Japan£©

¡°Anticarcinogenic activity of AHCC and PMP¡±
Buxiang Sun, et al. £¨Amino Up Chemical Co., Ltd., Japan£©
¡°Cancer£¬immunotherapy£¬HIV£¬and the use of AHCC¡±
Daniel Rubin, et al. £¨Naturopathic Family Care, Inc., Japan£©
¡°The effects of new immunotherapy on progressive gastric cancer¡±
Akikuni Yagita, et al. £¨Kinki University, Japan£©
¡°Effects of the natural IL-12 inducers on various progressive cancers¡±
Akikuni Yagita, et al. £¨Kinki University, Japan£©
¡°Effects of AHCC as a complementary therapy on prognosis of postoperative hepatocellular carcinoma patients¡±
Youichi Matsui, et al. £¨Kansai Medical University, Japan£©
¡°AHCC immunotherapy as a supplementary treatment to the postoperative patients¡±
Shigeru Teshima, et al. £¨Kansai Medical University, Japan£©
¡°Effect of AHCC on Ascites of patient with high level of CA-125¡±
Susumu Konda, et al. £¨Uchinada-onsen Hospital, Japan£©
¡°The role of AHCC on patients with advanced prostate cancer¡±
Aaron E. Katz, et al. £¨Columbia University, Japan£©
¡°Effects of AHCC on QOL of Various Patients¡±
Mitsuaki Iwamoto, et al. £¨Enzankai Hospital, Japan£©
¡°QOL Improvement in the Cancer Patients Treated with AHCC¡±
Francisco Contoreras, et al. £¨Oasis Hospital, Mexico£©
 
 
 
 
Á¶È¸¼ö 253

INFORMATION
  • ȸ»ç¸í : ÄÉÀ̾¾¿¡ÇÁÄÚ¸®¾Æ
  • ´ëÇ¥ÀÚ¸í : ±è°ÇÁ¾
  • ÁÖ¼Ò : ¼­¿ï½Ã ±¤Áø±¸ ¶Ò¼¶·Î 700, 202È£
  • ´ëÇ¥ÀüÈ­ : 02-3425-1139
  • ´ëÇ¥ÀüÈ­ : 02-3425-1139
LICENCE
  • »ç¾÷ÀÚµî·Ï¹øÈ£ : 220-81-86504
WEB MASTER
  • e-mail : customer@kcfkorea.com
  • °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ Ã¥ÀÓÀÚ : ±è¸íÈñ
SITEMAP
¸ðµç ÄÁÅÙÃ÷ÀÇ ¹«´ÜÀüÁ¦ ¹× ¸µÅ©¸¦ ±ÝÁöÇÕ´Ï´Ù.
Copyright(c) 1989 by KCFKOREA All Rights Reserved. Designed by www.raphaheal.com